Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q4 LONG ANSWER 10M ★ High-yield

Define Dengue Fever. Describe its classification, clinical features, investigations and management.

Pediatrics · Final Professional

Definition

  • Dengue is an acute arboviral infection caused by the dengue virus (a flavivirus, 4 serotypes den 1–4), transmitted by the Aedes aegypti mosquito.
  • A second infection with a different serotype increases the risk of severe disease (antibody-dependent enhancement).

Phases of Illness

Febrile phase (2–7 days) → Critical phase (around defervescence, days 3–7) — plasma leakage → Recovery phase — reabsorption of fluid

WHO Classification (2009)

CategoryFeatures
Dengue without warning signsFever + 2 of: nausea/vomiting, rash, aches, leucopenia, positive tourniquet test
Dengue with warning signsAbdominal pain, persistent vomiting, mucosal bleeding, lethargy, liver > 2 cm, rising haematocrit with rapid fall in platelets, clinical fluid accumulation
Severe dengueSevere plasma leakage (shock/DSS, fluid accumulation with respiratory distress), severe bleeding, or organ impairment

Clinical Features

  • High fever with severe headache, retro-orbital pain, myalgia and arthralgia ('breakbone fever'), and rash.
  • Positive tourniquet test, thrombocytopenia and leucopenia.
  • Plasma leakage (pleural effusion, ascites, rising haematocrit) in the critical phase → hypovolaemic shock (dengue shock syndrome).

Investigations

  • NS1 antigen (positive early, days 1–5); IgM/IgG serology (after day 5).
  • CBC — thrombocytopenia, leucopenia, and a rising haematocrit (a key marker of plasma leakage).
  • Serial monitoring of haematocrit, platelets and warning signs.

Management

  • No specific antiviral — treatment is supportive, centred on careful fluid management.
  • Isotonic crystalloid for those with warning signs/leakage, titrated to the haematocrit and vital signs (avoid both under- and over-hydration).
  • Paracetamol for fever; avoid aspirin and NSAIDs (bleeding risk).
  • Platelet transfusion only for significant bleeding — not for a low count alone.
  • Manage dengue shock syndrome with prompt fluid resuscitation.

Older (DHF/DSS) Grading

GradeFeatures
DFFever + non-specific symptoms
DHF IAbove + thrombocytopenia/haemoconcentration + positive tourniquet test
DHF IIGrade I + spontaneous bleeding
DHF III (DSS)Circulatory failure (narrow pulse pressure, hypotension)
DHF IV (DSS)Profound shock (undetectable BP/pulse)

Pathophysiology of Severe Dengue

Immune activation increases vascular permeability, causing plasma leakage (into pleural/peritoneal spaces), haemoconcentration and hypovolaemic shock; thrombocytopenia and coagulopathy contribute to bleeding — hence the emphasis on monitoring haematocrit and careful fluid therapy.

Criteria for Discharge

  • Afebrile > 24–48 h without antipyretics, improving clinically and appetite returning.
  • Rising platelet trend, stable haematocrit, and no respiratory distress from effusions/ascites.

Tourniquet Test

A blood-pressure cuff is inflated midway between systolic and diastolic for ~5 minutes; > 10–20 petechiae per square inch is positive, indicating capillary fragility — a simple bedside clue in dengue.

Warning Signs to Watch

  • Severe abdominal pain, persistent vomiting, mucosal bleeding, lethargy/restlessness.
  • Tender enlarging liver, and a rising haematocrit with a rapid drop in platelets — trigger closer monitoring/admission.

Prognosis

With timely recognition of the critical phase and careful fluid management, most children recover fully; deaths occur mainly from unrecognised plasma leakage/shock or severe bleeding — both largely preventable with monitoring.

Prevention

  • Vector control — eliminate Aedes breeding sites (stored water), larvicides, personal protection.
  • Community awareness; dengue vaccine only in seropositive individuals (per current guidance).

All questions in Infectious Diseases

  1. Q1Define Childhood Tuberculosis. Describe its pathogenesis, types, clinical features and treatment. ★
  2. Q2Define Enteric Fever. Describe its pathogenesis, clinical features, investigations and management. ★
  3. Q3Define Malaria. Describe its clinical features, investigations, management and prognosis. ★
  4. Q4Define Dengue Fever. Describe its classification, clinical features, investigations and management. ★
  5. Q5Define Measles. Describe its clinical features, investigations, management and stages. ★
  6. SN1Define HIV Infection in Children. Describe its clinical features, diagnosis and management. ★
  7. SN2Describe the including Neonatal Tetanus of Tetanus. ★
  8. SN3Define Chickenpox. Describe its clinical features, complications and management.
  9. SN4Define Mumps. Describe its clinical features, complications, management and prevention.
  10. SN5Define Rubella & Congenital Rubella Syndrome. Describe its prevention and diagnosis.
  11. SN6Define Diphtheria. Describe its clinical features, complications, management and types.
  12. SN7Describe the visceral Leishmaniasis of Kala-azar.

Every Pediatrics chapter →

Scroll to Top